iiinova — where your digital self keeps evolving

Reposted by Christopher Baladad, PharmD, BCIDP

Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 24/05/2025

🆕💫 Narrative review in ICM How to approach a patient hospitalized for pneumonia who is not responding to treatment? #idsky #EMIMCC link.springer.com/article/10.1...

1102

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 10/04/2025

What I wish I had right now, an already made newsletter on "Things We Do For No Reason: 'Continue IV Antibiotics While Inpatient, Then Discharge Home on Oral Antibiotics'" in patients that can otherwise tolerate oral therapy. Fewer lines, shorter stays, same outcomes. #IDSky #PharmSky

270

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 04/03/2025

For institutions that have sulbactam-durlobactam on formulary. What are your criteria for use? Do you use it first line for all CRABs? Has it replaced high dose ampicillin-sulbactam? #IDSky #Pharmsky

120

Reposted by Christopher Baladad, PharmD, BCIDP

Jonathan Ryder, MD @jonathanrydermd.bsky.social · 16/01/2025

Important article for #AMSSky, #TxID, #UTISky, and #IDSky in @cidjournal.bsky.social: In neutropenic & non-neutropenic cancer patients w/ & w/o catheters, the absence of nitrite/leukocyte esterase or WBC<10 had high NPV for clinically significant bacteriuria academic.oup.com/cid/advance-...

2276

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 08/01/2025

#IDSky #PharmSky Patient with M. abscessus bacteremia on iHD. 1. How are you dosing amikacin in these patients? 2. Do you have specific peak goals? 3. Do you omit amikacin entirely? If possible, you're willing to share protocols, that'd be extremely helpful!

351

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 27/11/2024

Where do we go from here with UTI WikiGuidelines and what do you use? This study used cephalexin @ variable doses), median txt 10d, and cefazolin MIC of <=16 as susceptible. (CLSI cut-off for uUTI). Personally, I use cephalexin 1000 mg PO QID x10-14d if cefazolin MIC <=2 for pyelonephritis.

240

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 21/11/2024

#IDSky #PharmSky Pt w/ MTB on RIPE w/ rifampin 1200 mg QD (TDM ✅) Smear (+) x3 mo. Now with (+) serum galactomannan (0.5) and worsening O2 status. ID wants to treat for aspergillosis. Would you start posa and continue rifampin or convert to rifabutin and start posa?

350

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 15/11/2024

Presented on ED abx stewardship to our new ED physician group. Highlighted our ASB treatment rates, educated on our UTI guidelines, and showed our compliance with STI screening with CDC recommendations. How do you engage your ED teams for abx stewardship? #IDsky #Pharmsky #Medsky

10236

Reposted by Christopher Baladad, PharmD, BCIDP

Ken Koon Wong @kenkoonwong.bsky.social · 10/11/2024

Does your ED use Dalbavancin for SSTi? If so, what's your experience like? Is it any different from Linezolid with re: patient experience/admission/readmission/relapse/recurrence? #IDsky

821

Christopher Baladad, PharmD, BCIDP @cbaladadpharmd.bsky.social · 10/11/2024

Hello #PharmSky #IDSky! I’m Chris, an ID pharmacist in San Diego, passionate about antimicrobial stewardship and resistance. Looking forward to connecting and learning with everyone here!

7364